Philippe Camus, M.D.

Dijon, France

Back to drug

The Drug-Induced Respiratory Disease Website

XX.d

Vasculitis, pulmonary (w/wo AH), extrathoracic, or systemic: ANCA-positive

See also 34859017

Publications

Shirai T, Suzuki J, Kuniyoshi S, Tanno Y, Fujii H

Granulomatosis with Polyangiitis Following Pfizer-BioNTech COVID-19 Vaccination.

Modern rheumatology case reports 2022 Mar 04;; — 2022 Mar 04

Hakroush S, Tampe B

Case Report: ANCA-Associated Vasculitis Presenting With Rhabdomyolysis and Pauci-Immune Crescentic Glomerulonephritis After Pfizer-BioNTech COVID-19 mRNA Vaccination.

Frontiers in immunology 2021;12;762006 — 2021 — 762006

Dube GK, Benvenuto LJ, Batal I

ANCA-associated Glomerulonephritis Following the Pfizer-BioNTech COVID-19 Vaccine.

Kidney international reports 2021 Aug 17;; — 2021 Aug 17

Villa M, Díaz-Crespo F, Pérez de José A, Verdalles Ú, Verde E, Ruiz FA, Acosta A, Mijaylova A, Goicoechea M

A case of ANCA-associated vasculitis after AZD1222 (Oxford-AstraZeneca) SARS-CoV-2 vaccination: casualty or causality?

Kidney international 2021 Aug 17;; — 2021 Aug 17

Shakoor MT, Birkenbach MP, Lynch M

ANCA-Associated Vasculitis Following the Pfizer-BioNTech COVID-19 Vaccine.

American journal of kidney diseases : the official journal of the National Kidney Foundation 2021 Jul 16;; — 2021 Jul 16